Validation of a next-generation sequencing oncology panel optimized for low input DNA

Gonzalez de Castro, 2013, Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance, Clin Pharmacol Ther, 93, 252, 10.1038/clpt.2012.237 Ferraz, 2011, Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules, J Clin Endocrinol Metab, 96, 2016, 10.1210/jc.2010-2567 Lindeman, 2013, J Mol Diagn, 15, 415, 10.1016/j.jmoldx.2013.03.001 Grossmann, 2012, Molecular testing in malignant melanoma, Diagn Cytopathol, 40, 503, 10.1002/dc.22810 Shi, 2012, Molecular testing in colorectal cancer: diagnosis of Lynch syndrome and personalized cancer medicine, Am J Clin Pathol, 137, 847, 10.1309/AJCPI83DINULUJNI Lee, 2013, Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis, J Natl Cancer Inst, 105, 595, 10.1093/jnci/djt072 Cheng, 2012, Molecular pathology of lung cancer: key to personalized medicine, Mod Pathol, 25, 347, 10.1038/modpathol.2011.215 Pritchard, 2011, Colorectal cancer molecular biology moves into clinical practice, Gut, 60, 116, 10.1136/gut.2009.206250 Stephens, 2012, The landscape of cancer genes and mutational processes in breast cancer, Nature, 486, 400, 10.1038/nature11017 2012, Comprehensive genomic characterization of squamous cell lung cancers, Nature, 489, 519, 10.1038/nature11404 2011, Integrated genomic analyses of ovarian carcinoma, Nature, 474, 609, 10.1038/nature10166 Lenk, 2014 Cottrell, 2014, Validation of a next-generation sequencing assay for clinical molecular oncology, J Mol Diagn, 16, 89, 10.1016/j.jmoldx.2013.10.002 Frampton, 2013, Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing, Nat Biotechnol, 31, 1023, 10.1038/nbt.2696 Fassina, 2012, Fine needle aspiration of non-small cell lung cancer: current state and future perspective, Cytopathology, 23, 213, 10.1111/j.1365-2303.2012.01005.x Travis, 2010, Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift, J Thorac Oncol, 5, 411, 10.1097/JTO.0b013e3181d57f6e Saieg, 2012, The use of FTA cards for preserving unfixed cytological material for high-throughput molecular analysis, Cancer Cytopathol, 120, 206, 10.1002/cncy.20205 Young, 2013, Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms, Cancer Cytopathol, 121, 688, 10.1002/cncy.21338 Karnes, 2014, Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung, Cancer Cytopathol, 122, 104, 10.1002/cncy.21361 Kanagal-Shamanna, 2014, Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics, Mod Pathol, 27, 314, 10.1038/modpathol.2013.122 de Leng, 2016, Targeted next generation sequencing as a reliable diagnostic assay for the detection of somatic mutations in tumours using minimal DNA Amounts from formalin fixed paraffin embedded material, PLoS One, 11, 10.1371/journal.pone.0149405 Mehrotra, 2017, Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratory, PLoS One, 12, 10.1371/journal.pone.0181968 Roy-Chowdhuri, 2018, Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling, Mod Pathol, 10.1038/s41379-018-0006-x Vanni, 2015, Next-generation sequencing workflow for NSCLC critical samples using a targeted sequencing approach by ion torrent PGM platform, Int J Mol Sci, 16, 28765, 10.3390/ijms161226129 Kadri, 2017, Clinical validation of a next-generation sequencing genomic oncology panel via cross-platform benchmarking against established amplicon sequencing assays, J Mol Diagn, 19, 43, 10.1016/j.jmoldx.2016.07.012